Correction, 18 September 2026: an earlier version of this post described April 28 as the end of the quarter. It is the date the results were reported.
What changed
$CNC reported results on April 28, 2026. EPS came in at $3.37, up from $2.90 in the same period a year earlier — a year-over-year increase of 16.2%. Revenue grew 5.1% over the same stretch.
The stock trades at $64.36 with a market cap of $31.64B, and the analyst consensus target sits at $65.17. The forward P/E is 18.3. We do not have guidance commentary from this report.
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.
What it means
The earnings picture here is cleaner than the headline financials might suggest at first glance. The trailing P/E reads zero in the data, which typically reflects a period of negative reported earnings dragging the trailing calculation — but the forward P/E of 18.3 tells a different story about where the business is heading. The EPS figure for the quarter reported on April 28, 2026 shows real momentum: $3.37 against $2.90 a year ago is a meaningful step up, not a rounding error.
The ACCE score of 64/100 breaks down in an interesting way. Momentum leads at 97/100 — the stock is up 126.7% over the past year, which is a striking run for a large managed-care name. Value scores 76/100, suggesting the market has not yet fully priced in the earnings improvement relative to peers. Growth sits at 56/100, consistent with the mid-single-digit revenue expansion. Quality is the weak spot at 27/100, and the underlying numbers back that up: ROE is -26.0% and net margin is -3.6%.
The one figure that cuts against the quality concern is FCF yield at 13.8%. That is a high number, and it signals that cash generation is running well ahead of what the net margin line implies. Earnings quality is flagged as strong in the data, which reinforces the idea that the reported EPS figure is not being flattered by one-time items.
The tension in $CNC right now is between a stock that has already moved sharply — up 126.7% in a year, trading near the analyst target of $65.17 — and fundamentals that are genuinely improving. EPS growth of 16.2% on 5.1% revenue growth means the company is expanding margins, even if the absolute margin level remains thin. Whether that margin expansion continues is the key question, and without guidance commentary we cannot say how management views the rest of the year.
For current price and score updates, see acceinvestments.com/stocks/CNC.
See the full picture, free
ACCE scores thousands of stocks across six valuation models, with fair value, conviction and the full thesis on every name. Start free, no card required.
